Viewing nowCombinationTelopine Tablet 40/5 mg
Telmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Genewon Science Co., Ltd.

MFDS item code 201605723 · Approved 2016.09.29 · Insurance code 671705110
Treatment of essential hypertension not controlled with monotherapy
This medication is used for patients with essential hypertension who have difficulty controlling blood pressure with telmisartan or amlodipine monotherapy. In other words, when blood pressure does not sufficiently decrease with monotherapy, this medication can be used to manage blood pressure more effectively.
The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended that the tablet be taken at the same time each day, if possible (e.g., in the morning). Before administering this medicine, it is recommended that the dose be adjusted using the individual components (telmisartan or amlodipine). However, if blood pressure is not adequately controlled with an individual component as described below, switching directly to this medicine may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. Patients taking telmisartan and amlodipine concomitantly may switch to this medicine (a fixed-dose combination containing the same amounts of each active ingredient) for convenience (limited to this medicine 40/5 mg). ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended that treatment be initiated at a low dose and the dose increased gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine dosage regimen is recommended for elderly patients, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring cautious administration’). In elderly patients aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be initiated at a low dose and the dose increased gradually.
The safety and efficacy of this medicine have not been established in pediatric patients aged 18 years or younger; therefore, its use is not recommended.
This medication can pose serious risks to the fetus during pregnancy, especially in the second and third trimesters, so it should not be taken by women who are pregnant or may become pregnant. This medication should not be administered to patients with hypersensitivity to the active ingredients, those with obstructive biliary disease, severe liver impairment, severe heart disease, pregnant women, or nursing mothers. Caution is necessary when using this medication in patients with impaired liver function, gastrointestinal diseases, renal artery hypertension, elderly patients, etc., and dosage adjustment or regular monitoring may be required. When taking this medication, side effects such as dizziness, edema, or hypotension may occur; if symptoms are severe, immediate consultation with a healthcare provider is required. It is important to regularly check blood pressure and kidney function, as blood pressure may decrease excessively or kidney function may be affected. There may be interactions when taken with other medications, so if you are taking other medications, it is essential to inform your doctor or pharmacist. Pregnant or nursing women should not take this medication, and if pregnancy is confirmed, the medication should be stopped immediately and a healthcare provider consulted. This medication is not recommended for children under 18 years of age, and elderly patients should use it with caution and adjust the dosage accordingly. In case of overdose, symptoms such as hypotension, dizziness, or heart problems may occur, so immediate medical attention is necessary.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in a special container that prevents light exposure. Additionally, it is important to maintain a temperature of 1 to 30 degrees Celsius when storing the medication. Proper storage will ensure the safe preservation of the medication's effectiveness.
White and light blue biconvex oval double-coated tablet.
30 tablets (10 tablets/PTP x 3), 30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Genewon Science Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
ILDONG Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.